Stereotaxis Inc. (NYSE American:STXS) traded today at a new 52-week high of $7.75. Approximately 718,000 shares have changed hands today, as compared to an average 30-day volume of 359,000 shares.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company’s mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company’s revenue generation is bifurcated into 3 segments that are Systems, Disposables, service, and accessories, and Sublease, out of which the majority of revenue is generated from the Disposables, service and accessories segment. The company generates the majority of revenue from the United States.
Stereotaxis Inc. (NYSE American:STXS) is currently priced 37.4% above its average consensus analyst price target of $4.57.
In the past 52 weeks, shares of Stereotaxis Inc. have traded between a low of $1.70 and a high of $7.75 and is now at $7.30, which is 329% above that low price.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer